How a new program is benefiting techs, pharmacists, and patients.
The smallest patients can sometimes present the biggest issues.
Why it’s vital for pharmacists to learn about this emerging field.
What do pharmacies have to do with the recent Surgeon General Advisory? A lot, actually.
New drugs for acute migraines are almost ready for prime time. Here's what you need to know.
A study found that apixaban is a safe alternative to VKAs for ablation of atrial fibrillation.
Andaxanet alfa has shown effectiveness for patients needing hemostasis.
Board-certified pharmacists are better prepared to deal with pediatric patients than others. Here’s why.
Could telemedicine be the answer to diabetes management problems?
The legalization of marijuana has consequences.